Noosa News
Sun Pharma slashes Tasmanian poppy production following slump in global demand for pain relief
The reduced need for surgical pain relief during the pandemic has forced Tasmanian poppy processor Sun Pharma to cut its growing area for the coming season.
Key points:
- Sun Pharma has slashed the size of its growing area across Tasmania as global demand for painkillers falls
- Twenty growers in the state’s south will be cut and a further 150 will have their contracts reduced
- Worldwide demand for opium-based pain relief dropped to an all-time low last year as elective surgeries were cancelled
The multinational, which contracts growers across the state to produce poppies for its factory at Latrobe, has also made two field officers redundant as part of the cuts.
Worldwide demand for opium-based pain relief dropped to an all-time low last…
-
Noosa News13 hours agoReubhan Ralph identified as man behind terrifying childcare centre incident in Peregian Springs on the Sunshine Coast
-
General11 hours agoPolice say new leads being pursued after baby’s body found in Alexander Heights stormwater drain
-
General19 hours agoQueensland announced as 2027 Women’s Softball World Cup host in first Australian event since 1965
-
Noosa News21 hours agoInquest into Rosemarie Campbell’s death three days after gastric bypass surgery hears of ‘massive loss’ to family